Deborah Palestrant
Partner @ 5AM Ventures
Cambridge, United States
Deborah Palestrant is a seed investor at 5AM Ventures in Cambridge focused on Medical and Health Care. Deborah Palestrant is Partner at 5AM Ventures. She attended D'Amore-McKim School of Business at Northeastern University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Deborah Palestrant invests in
Stages Deborah Palestrant invests in
Countries Deborah Palestrant invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Renasant Bio
|
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments. | $54.5M / Seed / Jul 10, 2025 | |
Latigo Biotherapeutics
|
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependenceor tolerability. | $150M / Series B / Mar 17, 2025 | |
|
Latigo Biotherapeutics
|
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependenceor tolerability. | $135M / Series A / Feb 14, 2024 |
Co-Investors
Westlake Village BioPartners
4 deals together
Foresite Capital
3 deals together
Access Biotechnology
1 deal together
Alexandria Venture Investments
1 deal together
Atlas Venture
1 deal together
Blue Owl
1 deal together
About 5AM Ventures
5AM Ventures is a venture capital firm that offers seed- and early-stage investments to its clients. The company’s client portfolio consists of firms in the biopharmaceutical, life sciences, medical technology, and research instrument industries. 5AM Ventures was founded in 2002 by John Diekman and Andrew Schwab and is based in California.
5AM Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Kush Parmar
Managing Partner
|
|||
Scott Rocklage
Founding Partner
|
|||
Andrew Schwab
Managing Partner
|
|||
|
Deborah Palestrant
Partner
|
|||
James W. Young
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Deborah Palestrant invest in?
Deborah Palestrant invests primarily in Medical, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Deborah Palestrant last invest?
The most recent investment recorded for Deborah Palestrant closed in Jul 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
